These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Interpretation of hemostatic and fibrinolytic markers]. Asakura H Rinsho Byori; 2011 Oct; 59(10):970-7. PubMed ID: 22184880 [TBL] [Abstract][Full Text] [Related]
7. How to investigate mild to moderate bleeding disorders and bleeding disorder of unknown cause. Casini A; Gebhart J Int J Lab Hematol; 2024 May; 46 Suppl 1():27-33. PubMed ID: 38454298 [TBL] [Abstract][Full Text] [Related]
8. Inherited disorders of the fibrinolytic pathway. Jain S; Acharya SS Transfus Apher Sci; 2019 Oct; 58(5):572-577. PubMed ID: 31427261 [TBL] [Abstract][Full Text] [Related]
9. Introduction. Rare bleeding disorders: general aspects of clinical features, diagnosis, and management. Peyvandi F; Palla R; Menegatti M; Mannucci PM Semin Thromb Hemost; 2009 Jun; 35(4):349-55. PubMed ID: 19598063 [TBL] [Abstract][Full Text] [Related]
10. Is my patient a bleeder? A diagnostic framework for mild bleeding disorders. Quiroga T; Mezzano D Hematology Am Soc Hematol Educ Program; 2012; 2012():466-74. PubMed ID: 23233621 [TBL] [Abstract][Full Text] [Related]
11. Thrombomodulin in patients with mild to moderate bleeding tendency. Mehic D; Tolios A; Hofer S; Ay C; Haslacher H; Downes K; Haimel M; Pabinger I; Gebhart J Haemophilia; 2021 Nov; 27(6):1028-1036. PubMed ID: 34628704 [TBL] [Abstract][Full Text] [Related]
12. Approaches to investigating common bleeding disorders: an evaluation of North American coagulation laboratory practices. Hayward CP; Moffat KA; Plumhoff E; Van Cott EM Am J Hematol; 2012 May; 87 Suppl 1():S45-50. PubMed ID: 22367923 [TBL] [Abstract][Full Text] [Related]
16. New data on FII, FV, FIX and thrombomodulin defects: blood keeps clotting in normal and in peculiar ways. Girolami A; Ferrari S; Girolami B; Randi ML Hematology; 2019 Dec; 24(1):232-237. PubMed ID: 31793409 [No Abstract] [Full Text] [Related]